Showing results (931-940 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|July 9, 2002
Suramin's development: what did we learn?Maninderjeet Kaur, Eddie Reed, Oliver Sartor, et al.Investigational New Drugs|August 31, 2002
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancerAlex A Adjei, Joel M Reid, Charles Erlichman, et al.Investigational New Drugs|August 31, 2002
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancerEmilio Esteban, Joaquín Fra, Marian Sala, et al.Investigational New Drugs|August 31, 2002
Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lung--a Kansas Cancer Institute and Thompson Cancer Survival Center StudyMichael Bastasch, Timothy J Panella, Shari L Kretzschmer, et al.Investigational New Drugs|August 31, 2002
Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomasRoger Kuhn, Arndt Hribaschek, Katrin Eichelmann, et al.Investigational New Drugs|July 1, 1992
Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group)R Nitschke, C Pratt, M Harris, et al.Investigational New Drugs|April 1, 1992
Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantationW J Slichenmyer, C F LeMaistre, D D Von HoffInvestigational New Drugs|December 1, 1987
Phase II evaluation of aclacinomycin-A in advanced ovarian carcinomaS Martino, D A Decker, H E Hynes, et al.Investigational New Drugs|January 1, 1987
Comparative in vitro activity of 4'-deoxy-4'-iododoxorubicin and other anthracyclines in the human tumor clonogenic assayJ E Schwartz, S E SalmonInvestigational New Drugs|November 27, 2021
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cellsHugo Passos Vicari, Juan Luiz Coelho-Silva, Diego A Pereira-Martins, et al.Pageof 372